EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
BEXSERO
Multicomponent Meningococcal B Vaccine
(recombinant, adsorbed)
EN
English
Anoro Ellipta 20 mcg
Added to your cart
59
Multicomponent Meningococcal B Vaccine
(recombinant, adsorbed)
BEXSERO was developed using a multiple antigen approach. Immunization with BEXSERO is intended to raise the titer of bactericidal antibodies that specifically bind the vaccine antigens fHbp, NadA, NHBA, and PorA P1.4 (the immunodominant antigen present in the OMV component). 1*
fHbp
Factor H binding protein
NadA
Neisserial adhesin A
NHBA
Neisseria Heparin Binding Antigen
OMV
Outer Membrane Vesicles that contain PorA 1.4
* Clinical significance unknown.
This page is for Healthcare Professionals only. If you are not a Healthcare Professional, please visit our consumer website BEXSERO.ca.